The role of heparan sulfate in enhancing the chemotherapeutic response in triple-negative breast cancer.
| Publicado en: | Breast Cancer Research Vol. 26; no. 1; pp. 1 - 15 |
|---|---|
| Autores principales: | , , , , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
BioMed Central
11/6/2024
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=180734466&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 180734466 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 14655411 8UYJ jtl: Breast Cancer Research issn: 14655411 maglogo: N pubinfo: dt: 11/6/2024 vid: 26 iid: 1 pid: 24147 pub: BioMed Central artinfo: ui: 180734466 10.1186/s13058-024-01906-6 180734466 ppf: 1 ppct: 14 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: The role of heparan sulfate in enhancing the chemotherapeutic response in triple-negative breast cancer. aug: au: Manouchehri, Jasmine M. Datta, Jharna Marcho, Lynn M. Reardon, Jesse J. Stover, Daniel Wesolowski, Robert Borate, Uma Cheng, Ting-Yuan David Schnell, Patrick M. Ramaswamy, Bhuvaneswari Sizemore, Gina M. Rubinstein, Mark P. Cherian, Mathew A. affil: https://ror.org/028t46f04 Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, 410 W 10th Ave., 43210, Columbus, OH, USA sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|